Author:
Sarikaya Ismet,Elgazzar Abdelhamid H.,Sarikaya Ali,Alfeeli Mahmoud
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference27 articles.
1. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5 T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial;Jambor;Acta Oncol,2016
2. 18F-fluoride PET/CT is highly effective for excluding bone metastases even in patients with equivocal bone scintigraphy;Bortot;Eur J Nucl Med Mol Imaging,2012
3. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F-NaF PET/CT, 18F-FDG PET/CT and whole-body MRI for detection of skeletal metastases;Iagaru;Clin Nucl Med,2013
4. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar BS, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT;Even-Sapir;J Nucl Med,2006
5. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT;Even-Sapir;J Nucl Med,2004
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献